Using chRDNA Genome-Editing Technology to Enhance Persistence Of Allogeneic T Cell Therapies
Time: 10:00 am
day: Advancing Durability & Persistence Focus Day
Details:
- Discuss chRDNAs, a next-generation CRISPR genome-editing technology
- Enhancing persistence of allogeneic CAR-T cell therapies through armoring strategies and immune cloaking
